Barbara Wirostko
Gründer bei Qlaris Bio, Inc.
Profil
Barbara Wirostko was the founder of Jade Therapeutics, Inc. (founded in 2012) and Qlaris Bio, Inc. (founded in 2019) where she held the titles of Chief Scientific Officer and Chief Medical Officer, respectively.
She previously worked as a Senior Medical Director at Pfizer Inc. from 2006 to 2010, Chief Medical Officer at Kiora Pharmaceuticals, Inc., and Chief Medical Officer at Altheos, Inc. from 2010 to 2013.
She also has an education background with a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Cornell University.
Aktive Positionen von Barbara Wirostko
| Unternehmen | Position | Beginn |
|---|---|---|
Qlaris Bio, Inc.
 Qlaris Bio, Inc. BiotechnologyHealth Technology Qlaris Bio, Inc. operates as a biotechnology company. The company was founded by Thurein Htoo and Barbara Wirostko and is headquartered in Wellesley, MA. | Gründer | 01.08.2019 |
Ehemalige bekannte Positionen von Barbara Wirostko
| Unternehmen | Position | Ende |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 23.08.2019 |
Jade Therapeutics, Inc.
 Jade Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Jade Therapeutics, Inc. develops pharmaceutical products. The company is based in Salt Lake City, UT. The company was founded by Barbara Wirostko. Jade Therapeutics was acquired by Kiora Pharmaceuticals, Inc. on March 07, 2016 for $5.10 million. | Gründer | 01.03.2016 |
Altheos, Inc.
 Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Corporate Officer/Principal | 18.11.2013 |
| PFIZER, INC. | Corporate Officer/Principal | 01.06.2010 |
Ausbildung von Barbara Wirostko
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Altheos, Inc.
Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Health Technology |
Jade Therapeutics, Inc.
Jade Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Jade Therapeutics, Inc. develops pharmaceutical products. The company is based in Salt Lake City, UT. The company was founded by Barbara Wirostko. Jade Therapeutics was acquired by Kiora Pharmaceuticals, Inc. on March 07, 2016 for $5.10 million. | Health Technology |
Qlaris Bio, Inc.
Qlaris Bio, Inc. BiotechnologyHealth Technology Qlaris Bio, Inc. operates as a biotechnology company. The company was founded by Thurein Htoo and Barbara Wirostko and is headquartered in Wellesley, MA. | Health Technology |
